Organisation paid for research Program year 2025 Source: CMS Open Payments

Austin Heart PA

Neither a doctor nor a teaching hospital

Research payments

$307,446

34 payments

Through program year 2025, Austin Heart PA is reported as receiving $307,446 in research payments, across 34 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$15,625	2
2024	Research	$52,190	3
2023	Research	$51,890	4
2022	Research	$107,655	4
2021	Research	$18,160	2
2020	Research	$35,452	5
2019	Research	$26,473	14

Breakdown

Who paid Research payments · program years 2019–2025

AstraZeneca Pharmaceuticals LP $167,885 8 payments
Novartis Pharmaceuticals Corporation $99,838 9 payments
Boston Scientific Corporation $39,723 17 payments

Studies the money was for Research payments · program years 2019–2025

Dapagliflozin in Acute Decompensated Heart Failure $167,885 8 payments
An Open-Label Extension Trial of the Phase III Lipid-Lowering Trials to Assess the Effect of Long Term Dosing of Inclisiran Given As Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C $97,683 8 payments
Navigate X4 Study $26,258 6 payments
Evolve II $6,640 2 payments
Ingevity $4,638 1 payment
A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established atherosclerotic cardiovascular disease $2,155 1 payment
Saval Pivotal $1,676 7 payments
Evolve Short Dapt $512 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.